A rare clinical case of syringomyelia progression in the presence of Chiari I malformation following the surgery
https://doi.org/10.37748/2686-9039-2023-4-3-5
Abstract
Today, an Arnold-Chiari malformation is defined as a developmental pathology of the craniovertebral junction manifested by a discrepancy between the volume and contents of the posterior cranial fossa, which in turn leads to compression of neurological structures and changes in the cerebrospinal fluid circulation. There are several theories of the correlation between Chiari malformation and syringomyelia, but the exact mechanism of syringomyelia development remains unclear.
This article describes a clinical case of treatment of a child with Chiari I malformation and syringomyelia within the cervical and thoracic segments of the spinal cord; after complete posterior fossa decompression, syringomyelia progressed in the early postoperative period with the development of a severe neurological deficiency. Since there is no standard treatment of such postoperative complications, a decision was made on the expectant management of the patient. From the twentieth day of the postoperative period, the patient showed complete regression of the neurological deficiency and positive MRI dynamics of syringomyelia.
The presented clinical case raises such issues as not only the pathophysiology of syringomyelia progression after complete posterior fossa decompression, but also the determination of patient management tactics in case of a complicated postoperative course of the disease.
The presented clinical case is of interest due to the rarely described aggravation of syringomyelia with enhancing neurological symptoms in the early postoperative period after complete posterior fossa decompression. Our observation suggests that the expectant management of the patient, despite syringomyelia progression with neurological deficiency aggravation after posterior fossa decompression, allowed a favorable long-term outcome of Chiari I malformation.
About the Authors
E. E. RostorguevRussian Federation
Eduard E. Rostorguev – Dr. Sci. (Med.), chief of neuro-oncological department, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.
ORCID: https://orcid.org/0000-0003-2937-0470, SPIN: 8487-9157, AuthorID: 794808, Scopus Author ID: 57196005138
Competing Interests:
отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
N. S. Kuznetsova
Russian Federation
Natalia S. Kuznetsova – MD, oncologist, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.
ORCID: https://orcid.org/0000-0002-2337-326X, SPIN: 8553-3081, AuthorID: 920734, ResearcherID: AGG-8960-2020
Competing Interests:
отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
A. A. Maslov
Russian Federation
Andrey A. Maslov – Dr. Sci. (Med.), professor, chief physician, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.
ORCID: https://orcid.org/0000-0001-7328-8074, SPIN: 5963-5915, AuthorID: 817983
Competing Interests:
отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
V. E. Hatyushin
Russian Federation
Vladislav E. Hatyushin – MD, neurosurgeon, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.
ORCID: https://orcid.org/0000-0002-1526-5197, SPIN: 5719-9345, AuthorID: 1129641
Competing Interests:
отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
B. V. Matevosyan
Russian Federation
Boris V. Matevosyan – MD, neurosurgeon, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.
Competing Interests:
отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
G. A. Reznik
Russian Federation
Gennadii A. Reznik – MD, neurosurgeon, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.
Competing Interests:
отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
O. V. Pandova
Russian Federation
Olga V. Pandova – MD, neurologist, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.
Competing Interests:
отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
E. V. Shalashnaya
Russian Federation
Elena V. Shalashnaya – senior researcher at the laboratory for the study of the malignant tumors pathogenesis, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.
ORCID: https://orcid.org/0000-0001-7742-4918, SPIN: 2752-0907, AuthorID: 476958, ResearcherID: AAE-4085-2022, Scopus Author ID: 55144159900
Competing Interests:
отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
References
1. Tubbs RS, Beckman J, Naftel RP, Chern JJ, Wellons JC, Rozzelle CJ, et al. Institutional experience with 500 cases of surgically treated pediatric Chiari malformation Type I. J Neurosurg Pediatr. 2011 Mar;7(3):248–256. https://doi.org/10.3171/2010.12.PEDS10379
2. Langridge B, Phillips E, Choi D. Chiari Malformation Type 1: A Systematic Review of Natural History and Conservative Management. World Neurosurg. 2017 Aug;104:213–219. https://doi.org/10.1016/j.wneu.2017.04.082
3. Oldfield EH. Pathogenesis of Chiari I - Pathophysiology of Syringomyelia: Implications for Therapy: A Summary of 3 Decades of Clinical Research. Neurosurgery. 2017 Sep 1;64(CN_suppl_1):66–77. https://doi.org/10.1093/neuros/nyx377
4. Zuev AA, Kostenko GV. Differentiated approach to surgical treatment of chiari anomaly of type 1 and syringomyelia. Bulletin of the National Medical and Surgical Center named after N. I. Pirogov 2018;13(1):53-57. (In Russ.).
5. Deora H, Behari S, Sardhara J, Singh S, Srivastava AK. Is Cervical Stabilization for All Cases of Chiari-I Malformation an Overkill? Evidence Speaks Louder Than Words! Neurospine. 2019 Jun;16(2):195–206. https://doi.org/10.14245/ns.1938192.096
6. Gil Z, Rao S, Constantini S. Expansion of Chiari I-associated syringomyelia after posterior-fossa decompression. Childs Nerv Syst. 2000 Sep;16(9):555–558. https://doi.org/10.1007/s003810000329
7. Chaouki Khoury. Chiari malformations [Internet]. UpToDate. 2003. Available at: https://www.uptodate.com/contents/ chiari-malformations, Accessed: 03.07.2023.
8. Kular S, Cascella M. Chiari I Malformation. 2022 Feb 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023 Jan.
9. Heiss JD, Patronas N, DeVroom HL, Shawker T, Ennis R, Kammerer W, et al. Elucidating the pathophysiology of syringomyelia. J Neurosurg. 1999 Oct;91(4):553–562. https://doi.org/10.3171/jns.1999.91.4.0553
10. Dzmitry V, Irina T, Hanna V. The Arnold-Chiari Anomaly: A Review of Literature. AJBSR. 2022 Apr 20;16(1):66. https://doi.org/10.34297/AJBSR.2022.16.002193
11. Heiss JD, Suffredini G, Smith R, DeVroom HL, Patronas NJ, Butman JA, et al. Pathophysiology of persistent syringomyelia after decompressive craniocervical surgery. Clinical article. J Neurosurg Spine. 2010 Dec;13(6):729–742. https://doi.org/10.3171/2010.6.SPINE10200
Supplementary files
Review
For citations:
Rostorguev E.E., Kuznetsova N.S., Maslov A.A., Hatyushin V.E., Matevosyan B.V., Reznik G.A., Pandova O.V., Shalashnaya E.V. A rare clinical case of syringomyelia progression in the presence of Chiari I malformation following the surgery. South Russian Journal of Cancer. 2023;4(3):44-50. https://doi.org/10.37748/2686-9039-2023-4-3-5